202 related articles for article (PubMed ID: 32882929)
21. Stimulation of catecholamine biosynthesis via the PKC pathway by prolactin-releasing peptide in PC12 rat pheochromocytoma cells.
Nanmoku T; Takekoshi K; Fukuda T; Ishii K; Isobe K; Kawakami Y
J Endocrinol; 2005 Jul; 186(1):233-9. PubMed ID: 16002552
[TBL] [Abstract][Full Text] [Related]
22. Impact of novel palmitoylated prolactin-releasing peptide analogs on metabolic changes in mice with diet-induced obesity.
Pražienková V; Holubová M; Pelantová H; Bugáňová M; Pirník Z; Mikulášková B; Popelová A; Blechová M; Haluzík M; Železná B; Kuzma M; Kuneš J; Maletínská L
PLoS One; 2017; 12(8):e0183449. PubMed ID: 28820912
[TBL] [Abstract][Full Text] [Related]
23. Effect of palmitoylated prolactin-releasing peptide on food intake and neural activation after different routes of peripheral administration in rats.
Mikulášková B; Zemenová J; Pirník Z; Pražienková V; Bednárová L; Železná B; Maletínská L; Kuneš J
Peptides; 2016 Jan; 75():109-17. PubMed ID: 26643957
[TBL] [Abstract][Full Text] [Related]
24. Palmitoylated PrRP analog decreases body weight in DIO rats but not in ZDF rats.
Holubová M; Zemenová J; Mikulášková B; Panajotova V; Stöhr J; Haluzík M; Kuneš J; Železná B; Maletínská L
J Endocrinol; 2016 May; 229(2):85-96. PubMed ID: 26906745
[TBL] [Abstract][Full Text] [Related]
25. Prolactin-releasing peptide activation of the prolactin promoter is differentially mediated by extracellular signal-regulated protein kinase and c-Jun N-terminal protein kinase.
Kimura A; Ohmichi M; Tasaka K; Kanda Y; Ikegami H; Hayakawa J; Hisamoto K; Morishige K; Hinuma S; Kurachi H; Murata Y
J Biol Chem; 2000 Feb; 275(5):3667-74. PubMed ID: 10652364
[TBL] [Abstract][Full Text] [Related]
26. Stimulation of corticotropin-releasing hormone-mediated adrenocorticotropin secretion by central administration of prolactin-releasing peptide in rats.
Matsumoto H; Maruyama M; Noguchi J; Horikoshi Y; Fujiwara K; Kitada C; Hinuma S; Onda H; Nishimura O; Inoue K; Fujino M
Neurosci Lett; 2000 May; 285(3):234-8. PubMed ID: 10806329
[TBL] [Abstract][Full Text] [Related]
27. Lipidized Prolactin-Releasing Peptide as a New Potential Tool to Treat Obesity and Type 2 Diabetes Mellitus: Preclinical Studies in Rodent Models.
Mráziková L; Neprašová B; Mengr A; Popelová A; Strnadová V; Holá L; Železná B; Kuneš J; Maletínská L
Front Pharmacol; 2021; 12():779962. PubMed ID: 34867411
[TBL] [Abstract][Full Text] [Related]
28. Lipidated PrRP31 metabolites are long acting dual GPR10 and NPFF2 receptor agonists with potent body weight lowering effect.
Alexopoulou F; Bech EM; Pedersen SL; Thorbek DD; Leurs U; Rudkjær LCB; Fosgerau K; Hansen HH; Vrang N; Jelsing J; Elster L
Sci Rep; 2022 Feb; 12(1):1696. PubMed ID: 35105898
[TBL] [Abstract][Full Text] [Related]
29. Central administration of prolactin-releasing peptide shifts the utilities of metabolic fuels from carbohydrate to lipids in chicks.
Tachibana T; Moriyama S; Khan MS; Sakamoto T
Physiol Behav; 2013 Aug; 120():40-5. PubMed ID: 23816984
[TBL] [Abstract][Full Text] [Related]
30. Liraglutide prevents beta-amyloid-induced neurotoxicity in SH-SY5Y cells via a PI3K-dependent signaling pathway.
Liu XY; Wang LX; Chen Z; Liu LB
Neurol Res; 2016 Apr; 38(4):313-9. PubMed ID: 27108910
[TBL] [Abstract][Full Text] [Related]
31. Regulation of the PRL promoter by Akt through cAMP response element binding protein.
Hayakawa J; Ohmichi M; Tasaka K; Kanda Y; Adachi K; Nishio Y; Hisamoto K; Mabuchi S; Hinuma S; Murata Y
Endocrinology; 2002 Jan; 143(1):13-22. PubMed ID: 11751586
[TBL] [Abstract][Full Text] [Related]
32. Anorexigenic lipopeptides ameliorate central insulin signaling and attenuate tau phosphorylation in hippocampi of mice with monosodium glutamate-induced obesity.
Špolcová A; Mikulášková B; Holubová M; Nagelová V; Pirnik Z; Zemenová J; Haluzík M; Železná B; Galas MC; Maletínská L
J Alzheimers Dis; 2015; 45(3):823-35. PubMed ID: 25624414
[TBL] [Abstract][Full Text] [Related]
33. Lupenone Protects Neuroblastoma SH-SY5y Cells Against Methamphetamine-Induced Apoptotic Cell Death via PI3K/Akt/mTOR Signaling Pathway.
Lee HS; Kim EN; Jeong GS
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32120831
[TBL] [Abstract][Full Text] [Related]
34. Isolation and characterisation of prolactin-releasing peptide in chicks and its effect on prolactin release and feeding behaviour.
Tachibana T; Moriyama S; Takahashi A; Tsukada A; Oda A; Takeuchi S; Sakamoto T
J Neuroendocrinol; 2011 Jan; 23(1):74-81. PubMed ID: 21083629
[TBL] [Abstract][Full Text] [Related]
35. Potential neuroprotective and anti-apoptotic properties of a long-lasting stable analog of ghrelin: an in vitro study using SH-SY5Y cells.
Popelová A; Kákonová A; Hrubá L; Kuneš J; Maletínská L; Železná B
Physiol Res; 2018 May; 67(2):339-346. PubMed ID: 29303606
[TBL] [Abstract][Full Text] [Related]
36. Stimulation of prolactin release by prolactin-releasing peptide in rats.
Matsumoto H; Noguchi J; Horikoshi Y; Kawamata Y; Kitada C; Hinuma S; Onda H; Nishimura O; Fujino M
Biochem Biophys Res Commun; 1999 Jun; 259(2):321-4. PubMed ID: 10362506
[TBL] [Abstract][Full Text] [Related]
37. Protective Effects of Fisetin Against 6-OHDA-Induced Apoptosis by Activation of PI3K-Akt Signaling in Human Neuroblastoma SH-SY5Y Cells.
Watanabe R; Kurose T; Morishige Y; Fujimori K
Neurochem Res; 2018 Feb; 43(2):488-499. PubMed ID: 29204750
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the binding of [(125)I]-human prolactin releasing peptide (PrRP) to GPR10, a novel G protein coupled receptor.
Langmead CJ; Szekeres PG; Chambers JK; Ratcliffe SJ; Jones DN; Hirst WD; Price GW; Herdon HJ
Br J Pharmacol; 2000 Oct; 131(4):683-8. PubMed ID: 11030716
[TBL] [Abstract][Full Text] [Related]
39. Prolactin-releasing peptide stimulates catecholamine release but not proliferation in rat pheochromocytoma PC12 cells.
Nanmoku T; Takekoshi K; Isobe K; Kawakami Y; Nakai T; Okuda Y
Neurosci Lett; 2003 Oct; 350(1):33-6. PubMed ID: 12962911
[TBL] [Abstract][Full Text] [Related]
40. TRAIL induces pro-apoptotic crosstalk between the TRAIL-receptor signaling pathway and TrkAIII in SH-SY5Y cells, unveiling a potential therapeutic "Achilles heel" for the TrkAIII oncoprotein in neuroblastoma.
Gneo L; Ruggeri P; Cappabianca L; Farina AR; Di Ianni N; Mackay AR
Oncotarget; 2016 Dec; 7(49):80820-80841. PubMed ID: 27821809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
